Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Leukemia

  Free Subscription


14.07.2025

1 Acta Haematol
3 Am J Hematol
2 Ann Hematol
1 Biochem Biophys Res Commun
2 Biochem Pharmacol
1 Blood
1 BMC Cancer
7 Br J Haematol
1 Cancer
3 Hematol Oncol Clin North Am
2 Leuk Lymphoma
3 Leukemia
1 PLoS One
1 Proc Natl Acad Sci U S A


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Haematol

  1. ZHANG L, Zhang Z, Lu A, Jia Y, et al
    Venetoclax-based regimen in refractory or relapsed pediatric acute lymphoblastic leukemia.
    Acta Haematol. 2025 Jul 8:1-18. doi: 10.1159/000547080.
    PubMed         Abstract available


    Am J Hematol

  2. HANNA J, Zabor EC, Albliwi M, El-Asmar J, et al
    Impact of Cytogenetic Response to Therapy on Long-Term Survival in Acute Myeloid Leukemia.
    Am J Hematol. 2025 Jul 11. doi: 10.1002/ajh.70000.
    PubMed         Abstract available

  3. LI M, Cui Q, Li X, Cui W, et al
    Tandem CD19/CD22 CAR T-Cell Therapy as First-Line Treatment for Adult Patients With High-Risk Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic Leukemia.
    Am J Hematol. 2025 Jul 5. doi: 10.1002/ajh.27752.
    PubMed        

  4. SHIMONY S, Luskin MR, Gangat N, LeBoeuf NR, et al
    Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): 2025 Update on Diagnosis, Pathophysiology, Risk Assessment, and Management.
    Am J Hematol. 2025;100:1408-1422.
    PubMed         Abstract available


    Ann Hematol

  5. CHENG T, Peng J, Liu Y, Yang S, et al
    Cladribine and medium-dose cytarabine intensified busulfan plus cyclophosphamide conditioning regimen for adults high-risk B-cell acute lymphoblastic leukemia.
    Ann Hematol. 2025 Jul 11. doi: 10.1007/s00277-025-06471.
    PubMed         Abstract available

  6. ZHANG D, Li Y, Liu T, Liu X, et al
    Efficacy and safety analysis of different treatment regimens in newly diagnosed acute promyelocytic leukemia.
    Ann Hematol. 2025 Jul 8. doi: 10.1007/s00277-025-06495.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  7. SANSACAR M, Pepe NA, Gencer Akcok EB, El Khatib M, et al
    Efficacy of combinatorial inhibition of Hedgehog and autophagy pathways on the survival of AML cell lines.
    Biochem Biophys Res Commun. 2025;775:152034.
    PubMed         Abstract available


    Biochem Pharmacol

  8. FANG L, Zuo L, Xing F, Wang Y, et al
    Repositioning miconazole: A novel drug for inducing cell death and differentiation in myeloid leukemia.
    Biochem Pharmacol. 2025 Jul 4:117126. doi: 10.1016/j.bcp.2025.117126.
    PubMed         Abstract available

  9. DONG S, Yang R, Wang Y, Fang X, et al
    A novel 3-alkenylindol-2-one derivative selectively inhibits the growth of acute myeloid leukemia via modulation of the MYC-PRMT pathway.
    Biochem Pharmacol. 2025;240:117111.
    PubMed         Abstract available


    Blood

  10. GRAINGER BT, Thompson PA, Cheah CY
    Doubling down: the new deal in the clinical management of double-refractory chronic lymphocytic leukemia.
    Blood. 2025;146:145-154.
    PubMed         Abstract available


    BMC Cancer

  11. NYEKO R, Kruger M, Niyonzima N, Stijn V, et al
    Paediatric acute myeloid leukaemia epidemiology, treatment approaches, and outcomes in africa: A review of the literature.
    BMC Cancer. 2025;25:1140.
    PubMed         Abstract available


    Br J Haematol

  12. AOKI T, Salib M, Suleman A, Ghanem N, et al
    Distinct characteristics and social determinants in adult T-cell leukaemia/lymphoma patients at a tertiary cancer centre in Canada.
    Br J Haematol. 2025 May 6. doi: 10.1111/bjh.20132.
    PubMed         Abstract available

  13. LUO Y, Fu Y, Kuang M, Wang J, et al
    Ciclosporin A potentiates venetoclax efficacy in FLT3-ITD AML by targeting the NFATC1-AKT-mTOR-BCL-2/MCL-1 signaling axis.
    Br J Haematol. 2025;207:46-58.
    PubMed         Abstract available

  14. BEHRENS YL, Reinkens T, Hofmann W, Gumann A, et al
    Genomic variant profiling in blast-phase paediatric chronic myeloid leukaemia: Predisposing and driving alterations.
    Br J Haematol. 2025;207:141-150.
    PubMed         Abstract available

  15. LIN ME, Hsu YC, Chiu HL, Yao CY, et al
    Inhibition of DOCK1 suppresses Notch signalling pathway and impairs leukaemogenesis.
    Br J Haematol. 2025;207:59-68.
    PubMed         Abstract available

  16. WILKE AC, Gokbuget N
    The role of blinatumomab in adult acute B lymphoblastic leukaemia.
    Br J Haematol. 2025;207:27-42.
    PubMed         Abstract available

  17. WANG M, Guo Z, Zhao S, Liu L, et al
    CD49d promotes T-cell senescence in chronic lymphocytic leukaemia.
    Br J Haematol. 2025;207:80-91.
    PubMed         Abstract available

  18. YE Y, Liu X, Dai H, Hu J, et al
    Venetoclax plus azacitidine with or without homoharringtonine followed by allogeneic haematopoietic cell transplantation in patients with relapsed/refractory acute myeloid leukaemia: A multicentre cohort study.
    Br J Haematol. 2025;207:151-161.
    PubMed         Abstract available


    Cancer

  19. KANTARJIAN H, Breccia M, Haddad FG, Hehlmann R, et al
    Management of chronic myeloid leukemia in 2025.
    Cancer. 2025;131:e35953.
    PubMed         Abstract available


    Hematol Oncol Clin North Am

  20. SWORDER B, Siddiqi T
    Immunotherapy in Chronic Lymphocytic Leukemia.
    Hematol Oncol Clin North Am. 2025 Jul 8:S0889-8588(25)00082.
    PubMed         Abstract available

  21. BHAT SA, Woyach JA
    Frontline Treatment of Chronic Lymphocytic Leukemia with Continuous Bruton's Tyrosine Kinase Inhibitors: A Comprehensive Overview.
    Hematol Oncol Clin North Am. 2025 Jul 7:S0889-8588(25)00078.
    PubMed         Abstract available

  22. PEREZ-CASTRO A, Abruzzo LV, Oakes CC
    The Chronic Lymphocytic Leukemia Epigenome: A Powerful and Stable Framework for Understanding Biological and Clinical Heterogeneity.
    Hematol Oncol Clin North Am. 2025 Jul 7:S0889-8588(25)00077.
    PubMed         Abstract available


    Leuk Lymphoma

  23. UYANIK MS, Jabbour E, Short N, Sasaki K, et al
    Nelarabine-related rhabdomyolysis in adult patients with T-cell lymphoblastic leukemia/lymphoma: a report of 6 patients.
    Leuk Lymphoma. 2025 Jul 6:1-3. doi: 10.1080/10428194.2025.2521649.
    PubMed        

  24. FENG J, Qian W, Shan S, Wang G, et al
    Azathioprine as a substitute for 6-mercaptopurine in childhood acute lymphoblastic leukemia: a single-center retrospective study.
    Leuk Lymphoma. 2025 Jul 6:1-9. doi: 10.1080/10428194.2025.2526795.
    PubMed         Abstract available


    Leukemia

  25. RETTINGER E, Heckl D, Gibson B, Sauer M, et al
    The hallmarks of hematopoietic stem cell transplantation for pediatric acute myeloid leukemia.
    Leukemia. 2025 Jul 9. doi: 10.1038/s41375-025-02685.
    PubMed         Abstract available

  26. SKULI SJ, Bakayoko A, Kruidenier M, Manning B, et al
    Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response.
    Leukemia. 2025 Jul 9. doi: 10.1038/s41375-025-02668.
    PubMed         Abstract available

  27. OKSA L, Moisio S, Maqbool K, Kramer R, et al
    Genomic determinants of therapy response in ETV6::RUNX1 leukemia.
    Leukemia. 2025 Jul 9. doi: 10.1038/s41375-025-02683.
    PubMed         Abstract available


    PLoS One

  28. ADOTEY G, Alolga RN, Quarcoo A, Gedel MA, et al
    Cytotoxic activity of Ganoderma weberianum-sichuanese isolated from the Lower Volta River Basin of Ghana against human prostate carcinoma (PC-3), leukemic T cell (Jurkat), and plasmacytoid dendritic cell (pDC)-derived acute leukemia (PMDC05) cell line
    PLoS One. 2025;20:e0327087.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  29. FIERRO C, Giovannini S, Moriconi V, Fiorilli C, et al
    The WWP1-JARID1B axis sustains acute myeloid leukemia chemoresistance.
    Proc Natl Acad Sci U S A. 2025;122:e2421159122.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.